Virginia State Board of Pharmacy v. Virginia Citizens Consumer Council, Inc.

1976-05-24

Headline: Decision strikes down Virginia ban on pharmacists' prescription‑drug price advertising, allowing truthful price information to be publicly advertised and helping consumers, especially the poor, sick, and elderly.

Holding: The Court held that truthful advertising of prescription‑drug prices is protected by the First Amendment and that Virginia may not completely suppress such price information, so the district court's injunction against enforcement was affirmed.

Real World Impact:

Allows pharmacists to advertise truthful prescription drug prices.
Gives consumers access to price information, helping poor and elderly shoppers.
Permits states to regulate false or misleading ads and use neutral time/place/manner rules.

Topics: prescription drug prices, price advertising rules, consumer information, free speech

Summary

Background

The Virginia State Board of Pharmacy enforced a law that made it unprofessional conduct for pharmacists to publish or advertise prices for prescription drugs. A group of consumers (an individual who needs daily medicines and two nonprofit organizations) challenged the law, and a three‑judge federal district court struck down the statute and enjoined enforcement. The Board appealed, raising the question whether truthful price advertising is commercial speech outside First Amendment protection.

Reasoning

The Court held that truthful advertising of prescription‑drug prices is protected speech. It explained that speakers and listeners both have First Amendment interests and that consumers have a right to receive information. The opinion rejected an absolute commercial‑speech exclusion and emphasized the public interest in price information, especially for the poor, the sick, and the elderly. The Court found Virginia's ban went too far because it completely suppressed truthful information and rested on a paternalistic judgment to keep the public ignorant. The Court affirmed the district court's judgment.

Real world impact

The decision permits pharmacists to advertise truthful prices for prescription drugs and requires states to leave open channels for such information. States may still regulate advertising that is false, misleading, or relates to illegal transactions, and they may use time, place, and manner rules that are content neutral. The Court also noted its holding was focused on pharmacists and prepackaged drugs, not necessarily on all professions or media.

Dissents or concurrances

Chief Justice Burger concurred, noting the case mostly involves retail advertising of prepackaged drugs. Justice Stewart emphasized that regulation of deceptive commercial speech remains permissible. Justice Rehnquist dissented, warning of broad consequences and questioning standing.